ActavisWe're seeing the exact same setup in shares of smaller pharma firm Actavis (ACT). That's not hugely surprising; correlation levels in the broad market are high to begin with, so firms within the same sector typically present similar trading opportunities at similar times. Like Amgen, ACT has resistance above shares (coincidentally also at $90) and uptrending support below.
5 Big Stock Trades Signaling 'Buy'
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts